Prevalence Study and Regular Practice Among General Practitioners in Populations at Risk of Chronic Obstructive Pulmonary Disease (COPD) in Latin America

NCT ID: NCT01493544

Last Updated: 2013-04-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1907 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-02-29

Study Completion Date

2012-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

PUMA is an observational, multicentre, multinational, cross-sectional study with primary care physicians (primary care, general and family physicians). Participants will be selected sequentially among patients at risk for Chronic Obstructive Pulmonary Disease (COPD) who attend primary care consultation (primary care, general and family physicians). The inclusion visit will be a regularly scheduled or spontaneous consultation for patients, and this appointment with the physician will not depend on the study. During the appointment, data will be collected from the patient and the physician.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PREVALENCE STUDY AND REGULAR PRACTICE (DIAGNOSIS AND TREATMENT) AMONG GENERAL PRACTICIONERS IN POPULATIONS AT RISK OF COPD IN LATIN AMERICA

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Obstructive Pulmonary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men or women aged more or equal than 40
* Current or former smokers and/or patients exposed to biomass combustion:

Cigarettes: more or equal than 10 packs/year; Pipes: more or equal than 50 pipes/year; Cigars: more or equal than 50 cigars/year; Combustion: more or equal 100 hours/firewood/year

Exclusion Criteria

* Pregnancy
* Patients with contraindications for spirometry
* Physical or mental disability rendering the patient unable to undergo a spirometry test and to contribute data to the study
* Heart rate ≥ 120 beats by minute
* Patients currently undergoing treatment for tuberculosis
* A patient who is participating in an interventional clinical trial or was previously included in this study
Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Maria Montes de Oca, Internist - Pulmonologist

Role: STUDY_CHAIR

Universidad Central de Venezuela

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Site

Belén de Escobar, Buenos Aires, Argentina

Site Status

Research Site

Ezeiza, Buenos Aires, Argentina

Site Status

Research Site

Los Polvorines, Buenos Aires, Argentina

Site Status

Research Site

Martínez, Buenos Aires, Argentina

Site Status

Research Site

Quilmes, Buenos Aires, Argentina

Site Status

Research Site

Ramos Mejía, Buenos Aires, Argentina

Site Status

Research Site

Capital Federal, Buenos Aires F.D., Argentina

Site Status

Research Site

Medellín, Antioquia, Colombia

Site Status

Research Site

Barranquilla, Atlántico, Colombia

Site Status

Research Site

Manizales, Caldas Department, Colombia

Site Status

Research Site

Armenia, Quindío Department, Colombia

Site Status

Research Site

Cali, Valle del Cauca Department, Colombia

Site Status

Research Site

Montevideo, Montevideo Department, Uruguay

Site Status

Research Site

Barquisimeto, , Venezuela

Site Status

Research Site

Caracas, , Venezuela

Site Status

Research Site

Maracaibo, , Venezuela

Site Status

Research Site

Porlamar, , Venezuela

Site Status

Research Site

Valencia, , Venezuela

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Argentina Colombia Uruguay Venezuela

References

Explore related publications, articles, or registry entries linked to this study.

Lopez Varela MV, Montes de Oca M, Rey A, Casas A, Stirbulov R, Di Boscio V; PUMA Team. Development of a simple screening tool for opportunistic COPD case finding in primary care in Latin America: The PUMA study. Respirology. 2016 Oct;21(7):1227-34. doi: 10.1111/resp.12834. Epub 2016 Jun 20.

Reference Type DERIVED
PMID: 27319305 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NIS-RLA-XXX-2011/1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Cartagena Cohort Study
NCT05339048 ENROLLING_BY_INVITATION